Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and t cells

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 5, Issue 4, 2004, Pages 213-219

  Graves, Michael C ^a   Fiala, Milan ^b,e   Dinglasan, Lu Anne V ^b   Liu, Nancy Q ^b   Sayre, James ^a   Chiappelli, Francesco ^c   van Kooten, Cees ^d   Vinters, Harry V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UCLA SCHOOL OF DENTISTRY   (United States)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adaptive immunity; Immunopathogenesis of ALS; Inflammation; Innate immunity; Mast cells

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CELL RECEPTOR; CYCLOOXYGENASE 2; NITRIC OXIDE SYNTHASE; PROTEIN ZO1;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD VESSEL INJURY; BRAIN CORTEX; BRAIN DISEASE; BRAIN INFARCTION; BRAIN REGION; CELL ACTIVATION; CELL DENSITY; CELL INFILTRATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEGENERATION; GRAY MATTER; HEMISPHERE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; MACROPHAGE ACTIVATION; MAST CELL; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; OCCIPITAL LOBE; PHAGOCYTOSIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL TRACT; SPINAL CORD DISEASE; T LYMPHOCYTE ACTIVATION; TIGHT JUNCTION; WHITE MATTER;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; CYCLOOXYGENASE 2; HUMANS; MACROPHAGES; MAST CELLS; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SPINAL CORD; T-LYMPHOCYTES;

EID: 12344310088     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/14660820410020286     Document Type: Article

References (37)

1. Maragakis NJ, Rothstein JD. Glutamate transporters in neurologic disease. Arch Neurol 2001; 58: 365-370.
2. Almer G, Guegan C, Teismann P et al. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 2001; 49: 176-185.
3. Maihofner C, Probst-Cousin S, Bergmann M, Neuhuber W, Neundorfer B, Heuss D. Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis. Eur J Neurosci 2003; 18: 1527-1534.
4. Yasojima K, Tourtellotte WW, McGeer EG, McGeer PL. Marked increase in cyclooxygenase-2 in ALS spinal cord: implications for therapy. Neurology 2001; 57: 952-956.
5. Drachman DB, Frank K, Dykes-Hoberg M et al. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol 2002; 52: 771-778.
6. Herschman HR, Reddy ST, Xie W. Function and regulation of prostaglandin synthase-2. Adv Exp Med Biol 1997; 407: 61-66.
7. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990; 323: 645-655.
8. Almer G, Teismann P, Stevic Z et al. Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology 2002; 58: 1277-1279.
9. Almer G, Vukosavic S, Romero N, Przedborski S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1999; 72: 2415-2425.
10. Drachman DB, Rothstein JD. Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis. Ann Neurol 2000; 48: 792-795.
11. Esposito B, De Santis A, Monteforte R, Baccari GC. Mast cells in Wallerian degeneration: morphologic and ultrastructural changes. J Comp Neurol 2002; 445: 199-210.
12. Shubayev VI, Myers RR. Up-regulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Res 2000; 855: 83-89.
13. Skaper SD, Pollock M, Facci L. Mast cells differentially express and release active high molecular weight neurotrophins. Brain Res Mol Brain Res 2001; 97: 177-185.
14. Skaper SD, Facci L, Romanello S, Leon A. Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway. J Neurochem 1996; 66: 1157-1166.
15. Bauer O, Razin E. Mast cell-nerve interactions. News Physiol Sci 2000; 15: 213-218.
16. Rouleau A, Dimitriadou V, Trung Tuong MD et al. Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis. J Neural Transm 1997; 104: 399-417.
17. Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992; 140: 691-707.
18. Fiala M, Liu QN, Sayre J et al. Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. Eur J Clin Invest 2002; 32: 360-371.
19. Fiala M, Liu NQ, Reddy S, Graves M. Macrophages infiltrate the brain and express COX-2 and iNOS in Alzheimer's disease and AIDS. Alzheimer's Reports 2001; 4: 1-7.
20. Twu C, Liu NQ, Popik W et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways. Proc Natl Acad Sci USA 2002; 99: 14386-14391.
21. Valle A, Zuber CE, Defrance T, Djossou O, De Rie M, Banchereau J. Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol 1989; 19: 1463-1467.
22. Hermann P, Van-Kooten C, Gaillard C, Banchereau J, Blanchard D. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation. Eur J Immunol 1995; 25: 2972-2977.
23. McGeer EG, McGeer PL. The importance of inflammatory mechanisms in Alzheimer's disease. Exp Gerontol 1998; 33: 371-378.
24. Akiyama H, Barger S, Barnum S et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21: 383-421.
25. Jackson M, Llado J, Rothstein JD. Therapeutic developments in the treatment of amyotrophic lateral sclerosis. Expert Opin Investig Drugs 2002; 11: 1164-1343.
26. Hayashi S, Sakurai A, Amari M, Okamoto K. Pathological study of the diffuse myelin pallor in the anterolateral columns of the spinal cord in amyotrophic lateral sclerosis. J Neurol Sci 2001; 188: 3-7.
27. Elliott JL. Cytokine up-regulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Brain Res 2001; 95: 172-178.
28. Alexianu ME, Kozovska M, Appel SH. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 2001; 57: 1282-1289.
29. Tikka TM, Vartiainen NE, Goldsteins G et al. Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease. Brain 2002; 125: 722-731.
30. Sanchez-Mejorada G, Alonso-deFlorida F. Changes in mast cell distribution in skeletal muscle after denervation. Muscle Nerve 1992; 15: 716-719.
31. Garlichs CD, Geis T, Goppelt-Struebe M et al. Induction of cyclooxygenase-2 and enhanced release of prostaglandin E(2) and I(2) in human endothelial cells by engagement of CD40. Atherosclerosis 2002; 163: 9-16.
32. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990; 346: 274-276.
33. Fiala M, Zhang L, Gan X-H et al. Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Molecular Medicine 1998; 4: 480-489.
34. Kunst CB, Mezey E, Brownstein MJ, Patterson D. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nat Genet 1997; 15: 91-94.
35. Wiedau-Pazos M, Goto JJ, Rabizadeh S et al. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996; 271: 515-518.
36. Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, Rothstein JD. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol Dis 2001; 8: 933-941.
37. Son M, Cloyd CD, Rothstein JD, Rajendran B, Elliott JL. Aggregate formation in Cu/Zn superoxide dismutase-related proteins. J Biol Chem 2003; 278: 14331-14336.